92 related articles for article (PubMed ID: 18832041)
1. Prostaglandin E2 negatively regulates AMP-activated protein kinase via protein kinase A signaling pathway.
Funahashi K; Cao X; Yamauchi M; Kozaki Y; Ishiguro N; Kambe F
Prostaglandins Other Lipid Mediat; 2009 Jan; 88(1-2):31-5. PubMed ID: 18832041
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2 induces vascular endothelial growth factor secretion in prostate cancer cells through EP2 receptor-mediated cAMP pathway.
Wang X; Klein RD
Mol Carcinog; 2007 Nov; 46(11):912-23. PubMed ID: 17427962
[TBL] [Abstract][Full Text] [Related]
3. PGE2 induces IL-1beta gene expression in mouse osteoblasts through a cAMP-PKA signaling pathway.
Park YG; Kang SK; Noh SH; Park KK; Chang YC; Lee YC; Kim CH
Int Immunopharmacol; 2004 Jun; 4(6):779-89. PubMed ID: 15135319
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of phosphorylation of the cAMP response element-binding protein after activation of EP2 and EP4 prostanoid receptors by prostaglandin E2.
Fujino H; Salvi S; Regan JW
Mol Pharmacol; 2005 Jul; 68(1):251-9. PubMed ID: 15855407
[TBL] [Abstract][Full Text] [Related]
5. Lack of interaction between prostaglandin E2 receptor subtypes in regulating adenylyl cyclase activity in cultured rat dorsal root ganglion cells.
Wise H
Eur J Pharmacol; 2006 Mar; 535(1-3):69-77. PubMed ID: 16545798
[TBL] [Abstract][Full Text] [Related]
6. A newly synthetic chromium complex-chromium (D-phenylalanine)3 activates AMP-activated protein kinase and stimulates glucose transport.
Zhao P; Wang J; Ma H; Xiao Y; He L; Tong C; Wang Z; Zheng Q; Dolence EK; Nair S; Ren J; Li J
Biochem Pharmacol; 2009 Mar; 77(6):1002-10. PubMed ID: 19073152
[TBL] [Abstract][Full Text] [Related]
7. The PGE2-induced inhibition of the PLD activation pathway stimulated by fMLP in human neutrophils is mediated by PKA at the PI3-Kgamma level.
Burelout C; Thibault N; Harbour D; Naccache PH; Bourgoin SG
Biochem Pharmacol; 2007 Sep; 74(5):730-41. PubMed ID: 17631865
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 stimulates the formation of mineralized bone nodules by a cAMP-independent mechanism in the culture of adult rat calvarial osteoblasts.
Kaneki H; Takasugi I; Fujieda M; Kiriu M; Mizuochi S; Ide H
J Cell Biochem; 1999 Apr; 73(1):36-48. PubMed ID: 10088722
[TBL] [Abstract][Full Text] [Related]
9. Regulation by AMP-activated protein kinase of PGE2-induced osteoprotegerin synthesis in osteoblasts.
Kainuma S; Otsuka T; Kuroyanagi G; Yamamoto N; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
Mol Med Rep; 2016 Apr; 13(4):3363-9. PubMed ID: 26935864
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2 promotes the cell growth and invasive ability of hepatocellular carcinoma cells by upregulating c-Myc expression via EP4 receptor and the PKA signaling pathway.
Xia S; Ma J; Bai X; Zhang H; Cheng S; Zhang M; Zhang L; Du M; Wang Y; Li H; Rong R; Shi F; Yang Q; Leng J
Oncol Rep; 2014 Oct; 32(4):1521-30. PubMed ID: 25109834
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin receptor EP2 is responsible for cyclooxygenase-2 induction by prostaglandin E2 in mouse skin.
Ansari KM; Sung YM; He G; Fischer SM
Carcinogenesis; 2007 Oct; 28(10):2063-8. PubMed ID: 17277233
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E2 regulates amyloid precursor protein expression via the EP2 receptor in cultured rat microglia.
Pooler AM; Arjona AA; Lee RK; Wurtman RJ
Neurosci Lett; 2004 May; 362(2):127-30. PubMed ID: 15193769
[TBL] [Abstract][Full Text] [Related]
13. Catechin-induced activation of the LKB1/AMP-activated protein kinase pathway.
Murase T; Misawa K; Haramizu S; Hase T
Biochem Pharmacol; 2009 Jul; 78(1):78-84. PubMed ID: 19447226
[TBL] [Abstract][Full Text] [Related]
14. PGE(2) induces COX-2 expression in podocytes via the EP(4) receptor through a PKA-independent mechanism.
Faour WH; Gomi K; Kennedy CR
Cell Signal; 2008 Nov; 20(11):2156-64. PubMed ID: 18762248
[TBL] [Abstract][Full Text] [Related]
15. The regulation of AMP-activated protein kinase by upstream kinases.
Carling D; Sanders MJ; Woods A
Int J Obes (Lond); 2008 Sep; 32 Suppl 4():S55-9. PubMed ID: 18719600
[TBL] [Abstract][Full Text] [Related]
16. Role of the atypical protein kinase Czeta in regulation of 5'-AMP-activated protein kinase in cardiac and skeletal muscle.
Ussher JR; Jaswal JS; Wagg CS; Armstrong HE; Lopaschuk DG; Keung W; Lopaschuk GD
Am J Physiol Endocrinol Metab; 2009 Aug; 297(2):E349-57. PubMed ID: 19625676
[TBL] [Abstract][Full Text] [Related]
17. Rho-kinase mediates spinal nitric oxide formation by prostaglandin E2 via EP3 subtype.
Matsumura S; Abe T; Mabuchi T; Katano T; Takagi K; Okuda-Ashitaka E; Tatsumi S; Nakai Y; Hidaka H; Suzuki M; Sasaki Y; Minami T; Ito S
Biochem Biophys Res Commun; 2005 Dec; 338(1):550-7. PubMed ID: 16188227
[TBL] [Abstract][Full Text] [Related]
18. EP2 and EP4 receptors differentially mediate MAPK pathways underlying anabolic actions of prostaglandin E2 on bone formation in rat calvaria cell cultures.
Minamizaki T; Yoshiko Y; Kozai K; Aubin JE; Maeda N
Bone; 2009 Jun; 44(6):1177-85. PubMed ID: 19233324
[TBL] [Abstract][Full Text] [Related]
19. Excretory-secretory products from Paragonimus westermani increase nitric oxide production in microglia in PKC-dependent and -independent manners.
Jin Y; Choi IY; Kim C; Hong S; Kim WK
Neurosci Res; 2009 Oct; 65(2):141-7. PubMed ID: 19539668
[TBL] [Abstract][Full Text] [Related]
20. Activation and signaling by the AMP-activated protein kinase in endothelial cells.
Fisslthaler B; Fleming I
Circ Res; 2009 Jul; 105(2):114-27. PubMed ID: 19608989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
